This inventor holds 12 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: The General Hospital Corporation, Biogen Idec Ma Inc., The Brigham and Women's Hospital, Inc.. Active years: 1998-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wayland, MA (US) (1998 - 2020)
- Boston, MA (US) (2020)
Company Filing History:
8 out of 3,073 
4 out of 216 
3 out of 1,428 
Years Active: 1998-2020
Title: The Innovative Journey of Joseph V. Bonventre
Introduction: Joseph V. Bonventre is a notable inventor based in Wayland, MA, with an impressive portfolio of 12 patents. His groundbreaking work in the fields of kidney injury diagnostics and organoid development has earned him recognition as a leading innovator in regenerative medicine.
Latest Patents: Among his latest innovations, Bonventre has developed two significant patents. The first patent, titled "Three-dimensional differentiation of epiblast spheroids to kidney organoids models stage-specific epithelial physiology, morphogenesis, and disease," explores the potential of human pluripotent stem cells (hPSCs) to recreate tissue-specific epithelial functions. This research provides insights into the role of hPSCs in regenerative therapies and disease modeling. The second patent focuses on "Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney." This invention underscores the importance of KIM-1 polypeptide as a biomarker for acute kidney injury and renal cell carcinoma, presenting methods for accurate diagnosis through blood sample analysis.
Career Highlights: Throughout his career, Bonventre has made significant contributions to the medical field, particularly in kidney health. His work combines innovative research with practical applications, as seen in his strategic roles at major organizations such as The General Hospital Corporation and Biogen Idec Massachusetts, Inc.
Collaborations: Bonventre has collaborated with esteemed colleagues in his research endeavors, including Veronique Bailly and Michele Sanicola-Nadel. These partnerships have enriched his projects and facilitated advancements in kidney-related therapeutics and diagnostics.
Conclusion: Joseph V. Bonventre's inventive contributions have profoundly impacted the landscape of kidney disease diagnosis and treatment. His dedication to innovation in regenerative medicine continues to pave the way for new breakthroughs, enhancing our understanding and management of kidney health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile